✦ LIBER ✦

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

✍ Scribed by Stein, Alexander; Kretzschmar, Albrecht; Behringer, Dirk; Wolff, Thomas; Zimber, Joachim; Hegewisch-Becker, Susanna; Kettner, Erika; Pflüger, Karl-Heinz; Kirsch, Andreas; Arnold, Dirk

Book ID: 121618104
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 198 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-454

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

6076 BOXER: A multicentre phase II trial

6076 BOXER: A multicentre phase II trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with liver-only metastases from colorectal cancer unsuitable for upfront resection

✍ Wong, R.; Saffery, C.; Barbachano, Y.; Chau, I.; Valle, J.; Hickish, T.; Mudan, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

6084 Efficacy and safety of bevacizumab-

6084 Efficacy and safety of bevacizumab-based combination regimens in patients with metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab + FOLFIRI vs. bevacizumab + XELIRI (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.P.; François, E.; Chauffert, B.; Boucher, E.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

6058 Phase I/II study of weekly intermit

6058 Phase I/II study of weekly intermittent capecitabine with bevacizumab and oxaliplatin on an every-2-week schedule for patients with untreated advanced colorectal cancer (CRC) final results

✍ Ramanathan, R.K.; Sehgal, R.; Rajasenan, K.K.; Crandall, T.L.; Balaban, E.P.; Pi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB